Apogee Therapeutics (APGE) Depreciation & Amortization (CF) (2024 - 2026)
Apogee Therapeutics (APGE) reported Depreciation & Amortization (CF) of $400000.0 for Q1 2026, up 100.0% year-over-year from $200000.0 in Q1 2025, and down 1.48% quarter-over-quarter from $406000.0 in Q4 2025.
Apogee Therapeutics (APGE) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $400000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $400000.0, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 318.23% YoY), and the FY2025 annual result was $1.4 million, up 609.0% from the prior year.
- Depreciation & Amortization (CF) slipped to $400000.0 in Q1 2026 per APGE's latest filing, from $406000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $406000.0 in Q4 2025 and troughed at $29000.0 in Q1 2024.
- A 3-year average of $224333.3 and a median of $200000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) surged 1011.11% in 2025, then jumped 100.0% in 2026.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $100000.0 in 2024, then surged by 306.0% to $406000.0 in 2025, then decreased by 1.48% to $400000.0 in 2026.
- Business Quant data shows APGE's Depreciation & Amortization (CF) at $400000.0 in Q1 2026, $406000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |